Molecular basis and generation of new compounds for probing phosphorylation-mediated signaling pathways
Molecular basis and generation of new compounds for probing phosphorylation-mediated signaling pathways
批准号:
06507001
负责人:
HIDAKA Hiroyoshi
金额:
$19.14万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
1994
资助国家:
日本
项目状态:
已结题
起止时间:
1994 至 1996
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Evidence accum ulated that protein kinases are involved in a variety of cellular processes such as depolarization -coupled smooth muscle contraction, secretagogues-stimulated release of biologically active substances from secretory cells, and mitogen-activated cell growth. Protein kinase inhibitors seem to be usful in studying physiological significance of protein kinases and part of tham probably works as medicines. This hypothesis has been, if any, proved with our H-series protein kinase inhibitors, H-89, H-7, KN-62, and HA-1077. Our goal of this research is to elucidate their actions and to construct some theory for molecular designing of protein kinase inhibitors. The results obtained are summarized as described below.1. The crystal structure of protein kinase A complex with H-7,8,89 was deterimined (Bossmeyer et. al. JBC,1996). This revealed that the adenine pocket of the protein accommodates well the isoquinokinesulfonamide of H-series compounds. It seems likely that the degree t … More o which the chemical structure added to the isoquinokinesulfonamide contributes to binding of the compounds determines their selectivity for protein kinases.2. HA-1077 shows a non-specific inhibition for a variety of protein kinases including myosin light chain kinase and is used as medicine for the treatment of cerebral vasospasm after subarachnoidal hemorrhage. By addition of some chemical groups to HA-1077, for example its methylation, such new compounds were found to change remarkably into specific inhibitors of some protein kinase. Combined with the findings described above, it is possible to amend H-series compounds by altering their chemical groups attached to the isoquinolinesulfonamide core.3. Based on structure-activity relationship, it was found that an isoquinolinesulfonamide was also indispensable for KN-62 to show calcium/calmodulin-dependent protein kinase inhibition, although the compound competed with calmodulin, but not with ATP.We consider that H-series compounds are seed compounds for new protein kinase inhibitors, and that they will bear more fruits when more information conceruing the structures of protein kinases are available. Less
期刊论文(22)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
H.Yokokura, Y.Okada, O.Terada, andH.Hidaka: "HMN-709, a chlorobenzenesulfonamide derivative and a new, membrane-permeable calmodulin antagonist." Jpn.J.Pharmacol.72. 127-135 (1996)
H.Yokokura、Y.Okada、O.Terada 和 H.Hidaka:“HMN-709,一种氯苯磺酰胺衍生物,一种新型膜渗透性钙调蛋白拮抗剂。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
H.Hidaka: "Protein Kinase inhibitors" Essays in Biochemistry. 28. 73-97 (1994)
H.Hidaka:“蛋白激酶抑制剂”生物化学论文。
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
H.Yokokura: "HMN-709, a chlorobenzenesulfonamide derivative and a new, membrane-permeable calmodulin antagonist." Jpn. J. Pharmacol.72. 127-135 (1996)
H.Yokokura:“HMN-709,一种氯苯磺酰胺衍生物,一种新型膜渗透性钙调蛋白拮抗剂。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
H.Hidaka: "Molecular and Cellular Pharmacology of a calcium/calmodulin-dependent protein kinase II (CaM kinase II) inhibitor, KN-62, and proposal of CaM kinase phosphorylation cascades." Intracellular Singnal Transduction, Advances in Pharmacology. 36. 19
H.Hidaka:“钙/钙调蛋白依赖性蛋白激酶 II (CaM 激酶 II) 抑制剂 KN-62 的分子和细胞药理学,以及 CaM 激酶磷酸化级联的提议。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
H.Hidaka and R.: "Kobayashi Protein kinase inhibitors." Essaya in Biochemistry. 73-97 (1994)
H.Hidaka 和 R.:“小林蛋白激酶抑制剂。”
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[]
通讯作者:
共 19 条
ELUCIDATION OF THE INTRACELLULAR CALCIUM SIGNAL TRANSDUCTION WITH THE MOLECULAR PHARMACOLOGICAL APPROARCH
-
批准号:06404019
-
项目类别:Grant-in-Aid for Scientific Research (A)
-
资助金额:$22.21万
-
财政年份:1994
-
负责人:HIDAKA Hiroyoshi
-
依托单位:
Nuclear magnetic resonance studies of calcyclin and annexin XI.
-
批准号:06044105
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$7.04万
-
财政年份:1994
-
负责人:HIDAKA Hiroyoshi
-
依托单位:
Establishment of the pharmacological sciences to elucidate the signal transduction system.
-
批准号:04304030
-
项目类别:Grant-in-Aid for Co-operative Research (A)
-
资助金额:$9.6万
-
财政年份:1992
-
负责人:HIDAKA Hiroyoshi
-
依托单位:
The Development of the Strategy for the Presumption of the Tertiary Structure of Protein Kinases by Specific Inhibitors
-
批准号:02557009
-
项目类别:Grant-in-Aid for Developmental Scientific Research (B)
-
资助金额:$7.42万
-
财政年份:1990
-
负责人:HIDAKA Hiroyoshi
-
依托单位:
Unification and reconstruction of myosin phosphorylation theory on contractile response of smooth muscle and nonmuscle cells.
-
批准号:01044066
-
项目类别:Grant-in-Aid for international Scientific Research
-
资助金额:$4.67万
-
财政年份:1989
-
负责人:HIDAKA Hiroyoshi
-
依托单位:
The role of Ca^<2+>-dependent protein kinases in central nervous system in health and diseases.
-
批准号:01440027
-
项目类别:Grant-in-Aid for General Scientific Research (A)
-
资助金额:$12.35万
-
财政年份:1989
-
负责人:HIDAKA Hiroyoshi
-
依托单位:
Development of analytical method of molecular function in protein kinases by using newly synthesized protein kinase inhibitor - affinity chromatography
-
批准号:62880018
-
项目类别:Grant-in-Aid for Developmental Scientific Research
-
资助金额:$4.03万
-
财政年份:1987
-
负责人:HIDAKA Hiroyoshi
-
依托单位:
Molecular pharmacological approarches of intracellular calcium regulatory mechanisms
-
批准号:62480119
-
项目类别:Grant-in-Aid for General Scientific Research (B)
-
资助金额:$3.84万
-
财政年份:1987
-
负责人:HIDAKA Hiroyoshi
-
依托单位:
Study on new types of calcium antagonists
-
批准号:58870019
-
项目类别:Grant-in-Aid for Developmental Scientific Research
-
资助金额:$3.97万
-
财政年份:1983
-
负责人:HIDAKA Hiroyoshi
-
依托单位:
国内基金
海外基金
抑制Protein Kinase D促进胚胎干细胞自我更新的分子机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:54万元
-
批准年份:2022
-
负责人:叶守东
-
依托单位: